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NanogNodal, a secreted factor known for its conserved functions in cell-fate speciﬁcation and the establishment of
embryonic axes, is also required in mammals to maintain the pluripotency of the epiblast, the tissue that gives
rise to all fetal lineages. Although Nodal is expressed as early as E3.5 in the mouse embryo, its regulation and
functions at pre- and peri-implantation stages are currently unknown. Sensitive reporter transgenes for two
Nodal cis-regulatory regions, the PEE and the ASE, exhibit speciﬁc expression proﬁles before implantation.
Mutant and inhibitor studies ﬁnd them respectively regulated by Wnt/β-catenin signaling and Activin/Nodal
signaling, and provide evidence for localized and heterogeneous activities of these pathways in the inner cell
mass, the epiblast and the primitive endoderm. These studies also show that Nodal and its prime effector,
FoxH1, are not essential to preimplantation Activin/Nodal signaling. Finally, a strong upregulation of the ASE
reporter in implanting blastocysts correlates with a downregulation of the pluripotency factor Nanog in the
maturing epiblast. This study uncovers conservation in the mouse blastocyst of Wnt/β-catenin and Activin/
Nodal-dependent activities known to govern Nodal expression and the establishment of polarity in the
blastula of other deuterostomes. Our results indicate that these pathways act early on to initiate distinct cell-
speciﬁcation processes in the ICM derivatives. Our data also suggest that the activity of the Activin/Nodal
pathway is dampened by interactions with the molecular machinery of pluripotency until just before
implantation, possibly delaying cell-fate decisions in the mouse embryo.stitut Jacques Monod, CNRS,
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Nodal, a TGFβ superfamily member involved in the speciﬁcation of
distinct cell-fates, has conserved functions in the establishment of
anterior–posterior (AP) and left–right (LR) polarities in deuterostome
embryos (Shen, 2007). In the mouse, Nodal has also an earlier role in
maintaining the undifferentiated status of the epiblast (Camus et al.,2006; Mesnard et al., 2006), the pluripotent tissue giving rise to all
fetal lineages and to the extra-embryonic mesoderm, but how this
relates to its conserved cell-fate speciﬁcation functions is unclear.
Epiblast precursor cells are intermingled with primitive endoderm
(PrE) precursor cells in the inner cell mass (ICM) of the E3.5 mouse
blastocyst. Between E3.5 and E4.0 these two cell populations start to
segregate to form separate layers (Rossant and Tam, 2009), a process
completed at E4.5 when the blastocyst implants in the uterus. The
epiblast, originally composed of apolar cells, becomes organized in an
epitheliumwhen the proamniotic cavity forms at E5.0. This correlates
with marked changes in its properties. Single E3.5 epiblast cells
injected in a host blastocyst can contribute to all fetal lineages of the
resulting chimera (Gardner, 1998), while post-implantation epiblast
cells cannot (Rossant, 2008). Corresponding cultured stem-cells
exhibit similar properties: embryonic stem-cells (mESCs) derived
from the epiblast of blastocysts can contribute to all fetal lineages
(Nichols and Smith, 2009), while epiblast stem-cells (mEpiSCs)
derived from the epiblast of E5.5 to E6.5 embryos can differentiate
in multiple lineages in vitro, but not in vivo (Tesar et al., 2007).
Markers speciﬁc for pre- or post-implantation epiblast typically see
their expression either down-regulated or up-regulated around the
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molecular level a transition takes place in the epiblast even before the
formation of the proamniotic cavity.
Pluripotency markers are turned down in Nodal−/− embryos, and
the epiblast prematurely undergoes anterior neural differentiation
(Camus et al., 2006; Mesnard et al., 2006). The earliest molecular
evidence of this phenotype has been detected at E5.0, suggesting an
even earlier requirement for Nodal. Key components of the Activin/
Nodal signaling pathway, such as Nodal, Smad 2 and 3, the co-receptor
Cripto and the transcription factor FoxH1, are indeed present in the
mouse embryo as early as E3.5 (Camus et al., 2006; James et al., 2005;
Mesnard et al., 2006). Furthermore, Lefty1, a Nodal target gene
encoding a Nodal antagonist, is also expressed from E3.5 onward
(Takaoka et al., 2006). Evidence therefore suggests that Nodal signals
before implantation. There is however no certainty regarding when,
between E3.5 and E5.0, it starts to be required. Interestingly, while the
Activin/Nodal signaling pathway is essential to maintain the self-
renewing capacity of mEPiSCs (Brons et al., 2007; Tesar et al., 2007), it
is not to maintain that of mESCs.
Four Nodal cis-regulatory elements have been characterized. The
NDE is a Notch-responsive element driving Nodal expression in the
node as soon as it appears at E7.5 (Adachi et al., 1999; Krebs et al.,
2003; Norris and Robertson, 1999; Raya et al., 2003). The AIE/LSE is
contributing to the asymmetrical expression of Nodal in left lateral
plate mesoderm (lpm) at E8.5, and may depend on Activin/Nodal
signaling (Saijoh et al., 2005; Vincent et al., 2004). The remaining two
elements, the PEE and the ASE, are active in the epiblast prior to the
onset of gastrulation (Adachi et al., 1999; Norris and Robertson, 1999)
(Ben-Haim et al., 2006). The ASE, like the AIE/LSE, also contributes to
the asymmetrical expression of Nodal at E8.5. The ASE is in the ﬁrst
intron of Nodal. It contains two functional FoxH1-Smad2,3 binding
motifs and acts as an auto-regulatory element allowing Nodal to
amplify its own expression (Norris et al., 2002; Yamamoto et al.,
2001). An ASE-based reporter transgene may therefore provide a
sensor for Activin/Nodal/Smad2,3 signaling. Deletions of the PEE or
the ASE result in phenotypes far less severe than that of Nodal−/−
embryos and characterized by later AP or LR patterning defects
(Norris et al., 2002; Vincent et al., 2003). These results emphasize the
reliance of Nodal on separate regulatory inputs to maintain its
expression.
We were interested to study the regulation and functions of Nodal
at peri-implantation stages. We generated transgenic lines where the
expression of ﬂuorescent proteins was placed under the control of the
PEE or the ASE, and found they providedmore sensitive tools thanwas
thus far available to study Nodal before and during implantation. We
show that Nodal expression and signaling activity in the mouse
blastocyst results from an interplay between an ancestral network of
interactions known to promote the establishment of axial polarity,
and the molecular machinery of pluripotency found in mammals.
Materials and methods
Reporter constructs and transgenesis
The PEE–hsp68p–3nls–d1eGFP, ASE–hsp68p–3nls–d2eYFP and
ASE–hsp68p–3nls–d2eCFP constructs contain the PEE or the ASE
sequence (Norris and Robertson, 1999), the Hsp68 promoter and a
sequence encoding 3NLS, subcloned within the pd1eGFPN1 the
pd2eYFPN1 or pd2eCFPN1 vector (Clontech) respectively. The d1EGFP
version of the GFP protein contains two PEST sequences, against one in
the d2EYFP and d2ECFP versions of YFP and CFP, to ensure rapid
proteasome-mediated degradation, resulting in half-lives of 1 hour
and 2 hours respectively in cell culture conditions (Li et al., 1998).
Following appropriate restriction enzyme digestions, DNA constructs
were gel-puriﬁed and resuspended in Tris 10 mM, EDTA 0.25 mM pH
7.5. Transgenic founders were obtained after microinjection of theconstructs into (C57BL/6 X CBA) F2 fertilized eggs (1 or 2 ng/ml in
injection buffer).
Mouse breeding and genotyping
The following lines were used: FoxHI (Hoodless et al., 2001),
ctnnb1tm2.1Kem/+ (Brault et al., 2001) designated β-catenin−/+ there-
after, ApcMin (Su et al., 1992) and NodalLacZ (Collignon et al., 1996).
Stable lines carrying the transgenes were maintained on a (C57BL/6 x
CBA)F1 background. After immuno-staining, embryos were individ-
ually digested and genotyped using Red Extract-N-Amp Kit (Sigma).
The NodalLacZ and FoxH1mutant alleles were genotyped as previously
described (Collignon et al., 1996; Hoodless et al., 2001). β-catenin
mutant and heterozygous embryos were identiﬁed using multiplex
PCR: 5′-CACCATGTCCTCTGTCTATCC-3′ and 5′-AAGTGAGAGTGAT-
GAAAGTTGTT-3′ for the wildtype allele; 5′-CACCATGTCCTCTGTC-
TATCC-3′ and 5′-TACACTATTGAATCACAGGGACTT-3′ for the mutant
allele. ApcMinmutant and heterozygous embryos were identiﬁed using
multiplex PCR: 5′-TAAAGACCAGGAAGCCTTGT-3′ and 5′-AATACCTC-
GCTCTCTCTCCA-3′ for the wildtype allele; 5′-TTCCACTTTGGCA-
TAAGGC-3′ and 5′-TTCTGAGAAAGACAGAAGTTA-3′ for the mutant
allele.
Embryo collection
Mice were maintained under a 12-hour light cycle, between 7 am
and 7 pm. Embryos used to screen and analyze transgenic lines were
obtained from natural matings between transgenic males and Swiss
wildtype (wt) females. Preimplantation embryos were ﬂushed from
uterine horns with M2 medium (Sigma). When collected for culture
they were rinsed in KSOM. Post-implantation embryos were recov-
ered in DMEM containing 10% fetal calf serum and 25 mM Hepes
buffer.
Whole mount in situ hybridization, immunostaining and β-galactosidase
staining
β-galactosidase detectionwas performed as described by (Whiting
et al., 1991). Whole mount in situ hybridization protocol was adapted
from (Perea-Gomez et al., 2004) and (Chazaud et al., 2006) (see
supplementary materials and methods). RNA probes were generated
from the following plasmids: Nodal exon2-3 (Perea-Gomez et al.,
2004) and Gdf3 (Levine and Brivanlou, 2006). For immunoﬂuorescent
(IF) detection of GFP, YFP, Nanog and Gata4, embryos were ﬁxed in 4%
paraformaldehyde, rinsed in PBST/BSA (PBS, 0.02% Tween, 2% BSA)
and permeabilized in PBS/0.5% Triton, and then incubated with the
primary antibodies (diluted in PBS, 0.1% Tween, 2% BSA). After
successive PBST/BSA washes embryos were incubated with the
secondary antibody. Antibodies were as follows: rabbit anti-GFP, 1/
500- Alexa 488 anti-rabbit, 1/200- Alexa 488 anti-chicken, 1/500-
Alexa 568 anti-rabbit, 1/250 (Molecular Probes); chicken anti-GFP, 1/
1000-rabbit anti-Nanog, 1/250 (abcam); rabbit anti-Gata4, 1/250
(Santa Cruz Biotechnology). Nuclei were stained with Hoechst 33342
and cortical actin was marked with 0.5 μg/ml Alexa 647-conjugated
Phalloidin (both Molecular probes).
Inhibition of ALK4/5/7 receptors
Isolated blastocysts were transferred to an 8-well Netwell plate
(Costar) with 400 μl of G2v5PLUS(Vitrolife). They were cultured for
14 hours at 37 °C/5% CO2 in the presence of 20, 40, 50, 100 or 200μM
SB-431542 (Sigma) in DMSO, to test for dose toxicity and effective-
ness. Control embryos were cultured in the presence of the same
amount of DMSO. In our hands, treatment with 40 μM SB-431542 was
required to signiﬁcantly decrease the activity of the ASE-YFP
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chosen to perform inhibition experiments.Imaging and image processing
Acquisitions were performed using confocal microscopes (Leica
TCS SP5) and a spinning disk microscope with a Coolsnap HQ2 high-
resolution camera. The objectives used to acquire E3.5–E5.5, E6.5 and
E8.5 embryos were a 40×, a 20× and a 5×, respectively. Acquisition
software was LAS AF (Leica) for the SP5 and Metamorph 7 (Universal
Imaging) for the Spinning disk. Image stacks were generated using
ImageJ software (http://rsbweb.nih.gov/ij/) with the MBF ImageJ for
Microscopy collection of plugins by Tony Collins (http://rsbweb.nih.
gov/ij/plugins/mbf-collection.html) installed. To count cells, each
nuclei was marked in ImageJ using the Paintbrush Tool, and then
counted using the “Particle Analysis/3D objects counter” plug-in.Bio-informatics analysis
Detection of conserved regions
A pair of genomic sequences is called alignment-conserved if their
optimal alignment has a statistically signiﬁcant score and the
sequences are not repeats. The algorithm employed to comprehen-
sively detect alignment-conserved non-coding regions at the Nodal
locus as potential conserved regulatory modules essentially computes
an optimal alignment for every pair of 100- bp fragments, comparing
mouse to each of the other species. When comparing two sequences
of 100 kb the algorithm compares in the order of 1010 pairs of 100-
mers. The statistical evaluation of sequence alignment scores is
greatly simpliﬁed by this approach as all aligned sequences have the
same length.PSSM scanning procedure
Position-speciﬁc scoring matrices (PSSMs) from TRANSFAC were
applied to the PEE* sequence to search for putative binding sites. 0-
order and 3rd-order Markov models were used to evaluate matches
found in PEE* against background. The likelihood of binding in each
species was evaluated individually and the geometric mean to
aggregate likelihoods across species was used. Brieﬂy, sequences
were scanned using PSSMs extracted from the TRANSFAC database. A
PSSM of length K induces a distribution over K-mers that models
binding sites for the transcription factor(s) it represents. Each position
is modeled independently in this distribution. The PSSM can be
represented as a matrix, P, where Pk, b represents the probability of
seeing base b at position k in the PSSM. Given a K-mer, W=w1...wK,
and using a simple uniformbackgroundmodel, the log odds ratio L(W)
between the binding sitemodel (the PSSM) and a uniformbackground
model, [L(W)=K log4+Σ κκ-1 logρκ,wκ+V], can be calculated where V
is a prior representing how likely one believe binding to be. V of−4.7
(all logarithms to base 10) was used based on experience analyzing
other loci. The mouse sequences were analyzed but the log-odds ratio
using information from the human and cow sequences were adjusted.
The human and cow sequenceswere scanned for the TRANSFACPSSMs
independently using the sameprocedure. The log-odds ratio that there
is at least one binding site for each PSSM in each sequence was
calculated. Then the log-odds ratio for each putative binding site in the
mouse sequences by taking the average of its log-odds ratio with the
log-odds ratio that the PSSM binds anywhere in each of the conserved
human and cow sequences were adjusted. This heuristic captures the
idea that one would expect the binding sites to be conserved across
the species. An average was taken rather than a sum, as the
sequences were selected for their conservation and are therefore not
independent.Results
We used nuclear destabilized versions of the ﬂuorescent proteins
(FPs) GFP, YFP or CFP to obtain a more tractable and dynamic reading
of the transgenes' activities (Fig. 1A).
Validation of PEE-GFP transgenic lines at post-implantation stages
Four out of the nine PEE-GFP lines produced showed a similar GFP
expression proﬁle in the epiblast at E5.5 and E6.0, with characteristic
proximal and posterior restrictions. This proﬁle was consistent
with that obtained with the ASE-deleted NodalΔ600LacZ allele, and the
PEE-LacZ reporter transgene (Fig. 1 B, C; (Ben-Haim et al., 2006; Norris
and Robertson, 1999). The PEE-GFP line showing the strongest signal
was thus picked to investigate PEE activity and regulation. Immuno-
ﬂuorescent (IF) detection of the GFP proved to be a sensitive and
efﬁcient method to collect expression data. FP localization experi-
ments presented here were therefore done by IF.
Validation of ASE-FP transgenic lines at post-implantation stages
One out of three ASE-YFP transgenic lines and two out of nine
ASE-CFP transgenic lines expressed the FPs at detectable levels and
showed patterns consistent with that of the ASE-LacZ transgenic line
(Norris and Robertson, 1999). The ﬂuorescence was detected in the
epiblast at E5.25, E5.5 and E6.0 (Figs. 1E; S1A, B; S2D), and transiently
in the left lpm at E8.5 (Fig. 1D; Figs. S1C, D), tissues where the ASE is
known to be active.While β-galactosidase staining is still visible in the
left lpm of 12-somite stage NodalLacZ and ASE-LacZ embryos,
destabilized FPs were not detected in this tissue beyond the 5-somite
stage, attesting of their rapid degradation (Table S1; Fig. S1C–F).
No signal was found in the visceral endoderm (VE) of any of the
ASE-FP lines (Fig. 1E). Since intronic sequences containing the ASE
were previously reported as driving the expression of Nodal in the VE
at pre-gastrulation stages (Adachi et al., 1999; Norris and Robertson,
1999) the matter was further investigated using the original ASE-LacZ
line. Almost allASE-LacZ embryos analyzed at E5.5 and E6.0 (n=7/8 and
n=7/8 respectively; Fig. 1F; S2A) showed β-galactosidase activity
exclusively in the epiblast. Only two embryos showed staining in a few
VE cells. We conﬁrmed that E5.5 and E6.0 NodalLacZ/+ embryos exhibit
β-galactosidase activity in theVE covering the embryonic region (Varlet
et al., 1997), while NodalΔ600LacZ/+ embryos, where the ASE is deleted in
the NodalLacZ allele, lack this activity in the VE (Fig. 1G, C; S2C). These
results demonstrate the ASE is necessary but not sufﬁcient to drive
expression in the VE at pre-streak stages, suggesting it synergizes with
another sequence element, as yet unidentiﬁed, to generate Nodal VE
expression.
The ASE-YFP transgene was then introduced into Nodal and FoxH1
mutant backgrounds to further its validation (Hoodless et al., 2001).
No expression was detected in E5.5 Nodal−/− embryos (n=6/6;
Fig. 1H), consistent with previous studies (Brennan et al., 2001).
Similarly, no expression was detected at E5.5 in the absence of FoxH1
(n=7/7; Fig. 1I), as reported for the ASE-LacZ transgene at E6.5
(Norris et al., 2002). Together our results establish that the ASE-YFP
transgenic line harbors an adequate reporter for the Nodal/FoxH1-
dependent activity of the endogenous ASE.
The transgenes are active at peri-implantation stages
In contrast to post-implantation stages, where direct visualisation
of the FPs is possible in both transgenic lines, only the ASE-YFP
transgene delivers a robust ﬂuorescent signal at preimplantation
stages. Reliable detection of PEE-GFP expression at preimplantation
stages requires IF or ISH. For both transgenes, the earliest expression
was detected at E3.5, but the theoretical maximum ratio of 50% of
ﬂuorescent embryos in litters sired by heterozygous males is only
Fig. 1. Post-implantation validation of PEE-GFP and ASE-YFP expression proﬁles. (A) PEE-GFP and ASE-YFP constructs. Pr. HSP68: hsp68 minimal promoter; grey box: NLS; d1EGFP:
destabilized EGFP; d2EYFP: destabilized EYFP. (B) E5.5 PEE-GFP embryo. Maximum intensity projection of confocal stack. (C) X-Gal stained E5.5 NodalΔ600LacZ/+ embryo. (D) E8.5
ASE-YFP embryo showing expression in the left lpm. Maximum intensity projection of a confocal stack. (E) E5.5 ASE-YFP embryo. Single confocal section, showing YFP in the epiblast
but not in the VE, and (F) similar expression proﬁle in an X-Gal stained E5.5 ASE-LacZ transgenic embryo. (G) X-Gal stained E5.5NodalLacZ/+ embryo, showing β-galactosidase activity
in the epiblast and the embryonic VE. Single confocal sections of, (H) an E5.5Nodal−/− embryo and (I) an E5.5 FoxH1−/− embryo, both carrying ASE-YFP but showing no expression of
the transgene. FPs (in green) are detected by IF in B, D, E, H and I. Cortical actin (in red) is stained with Alexa 647-conjugated Phalloidin. Epi: epiblast; VE: visceral endoderm; DVE:
distal visceral endoderm; ExE: extra-embryonic ectoderm; n: number of embryos analysed. Scale bar=25 μm.
353C. Granier et al. / Developmental Biology 349 (2011) 350–362reached at E4.5 (Fig. 2). Analysis of these ISH and IF results (data not
shown) indicates that the two transgenes are activated in a
comparable fraction of the embryos at these stages and suggest thatFig. 2. The PEE-GFP and ASE-YFP transgenes are activated in E3.5-E4.5 blastocysts.
Comparison of the percentage of ﬂuorescent embryos in litters sired by transgenic PEE-
GFP or ASE-YFP heterozygous males, with respect to dissection times (between
brackets). An embryo is scored positive if it contains at least one ﬂuorescent cell.the longer half-life of d2EYFP (see Materials and Methods) allows
detection of lower expression levels than d1EGFP.
To understand how the PEE and the ASE may contribute to Nodal
expression in the ICM, the nascent epiblast and the PrE (Mesnard
et al., 2006; Takaoka et al., 2006), the expression of the transgeneswas
characterized at pre- and peri-implantation stages.
The PEE-GFP transgene marks a subset of ICM and epiblast cells
Thirty-seven ﬂuorescent PEE-GFP embryos between E3.5 and E5.0
were distributed in four classes according to their morphology: E3.5;
young E4.5; implanted E4.5; E5.0. Their expression patterns were
studied by confocal microscopy. The three E3.5 GFP-positive embryos
obtained showed only one (Fig. 3A) or two ﬂuorescent ICM cell, close
to the mural/polar trophectoderm (TE) junction. Most young E4.5
stage transgenic embryos showed a higher number of GFP-positive
cells (between 1 and 4; median=3), consistently forming a tight
group in the epiblast (n=13/14; Fig. 3B). This could be due to the
activation of the transgene being dependent on a local signal and/or
Fig. 3. PEE-GFP expression increases in the epiblast between E3.5 and E5.0. (A) E3.5 blastocyst. (B) Young E4.5 blastocyst. (C) Implanted E4.5 blastocyst. (D) E5.0 embryo. GFP (green;
maximum intensity projections of confocal stacks) and cortical actin (red; single confocal sections) are detected as before. ICM: inner cell mass; TE: trophectoderm; Epi: epiblast;
PrE: primitive endoderm. Scale bar=25 μm.
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remaining at ﬁrst in close contact. In older E4.5 embryos, an increase
in the number of GFP-positive cells correlates with their distribution
spreading out within the epiblast (Fig. 3C; n=12/17). Expression
of the PEE-GFP transgene is never detected in the PrE (n=0/31). The
increase in the number of expressing cells could result from the
inducing signal gaining in strength and/or more epiblast
cells becoming capable of expressing the transgene. By E5.0, all
epiblast cells are ﬂuorescent (Fig. 3D; n=3). They exhibit a range
of intensities, but the resulting heterogeneity shows no speciﬁc
pattern.
Wnt/β-catenin signaling is upstream of PEE activity at peri-implantation
stages
To investigate what upstream signals are important for the
expression of Nodal, we performed an extensive bioinformatics
analysis of the DNA sequence separating the transcription start site
(TSS) of Nodal from that of the Paladin gene in mouse, human, cow
and dog. Every 100 bp fragment in mouse was compared to every
100 bp fragment in the other species using optimal sequence
alignments. Two clusters of conserved sequences were identiﬁed,
and appeared associated to either gene (Fig. S3). The cluster closest to
Nodal comprised four conserved stretches, with the most 5’
corresponding to a 125 bp long sequence within the 1.8 kb PEE
(Fig. 4A). Position-speciﬁc scoring matrices (PSSMs) from TRANSFAC
were applied to this 125 bp sequence to search for putative binding
sites (Matys et al., 2003). An algorithm was used to rank their
likelihood of being functional, thus highlighting a number of sites of
interest. The best hits were for two LEF/TCF binding sites (Fig. 4B),
which had also been recognized in (Ben-Haim et al., 2006). This was
interesting, as LEF/TCF factors are effectors of the canonical Wnt/β-
catenin signaling pathway (Arce et al., 2006). This pathway acts
upstream of the genetic cascade, including Nodal homologues, that
establishes the embryonic axis in other vertebrates and in sea-urchin
(Agius et al., 2000; Range et al., 2007; Schier, 2001; Stern, 2006). It
was reported that Nodal is expressed in E6.0 β-catenin−/− embryos
(Morkel et al., 2003). We found that the ASE-YFP transgene is also
expressed in E5.5 β-catenin−/− embryos (Brault et al., 2001), attesting
that Activin/Nodal signaling is still active in these (Fig. S4A, B). In
contrast, the PEE-GFP transgenewas found inactive inE5.25β-catenin−/−
embryos (Fig. S4C, D), a result consistent with the reported down-
regulation of a PEE-LacZ transgene in the PS of E6.0Wnt3−/− embryos
(Ben-Haim et al., 2006), further demonstrating that Wnt/β-catenin
signaling contributes to Nodal regulation via the PEE.
To test the implication of the canonical Wnt pathway in the
regulation of the PEE at early stages, PEE-GFP expression was analysed
in the context of loss-of-function or gain-of-function mutations for
this pathway. First, we found that E4.75 β-catenin−/− embryos do not
express the transgene (n=5; Fig. 4C, D). This is the earliest defectcharacterized in β-catenin mutants so far, and a clear indication that
PEE activity is dependent on canonical Wnt signaling before
implantation.
Second, we used the ApcMin mutation in which a truncated form of
the adenomatous polyposis coli (Apc) gene prevents the formation of
the APC complex, leading to cytoplasmic and nuclear accumulation of
β-catenin and constitutive activation of the pathway as early as E4.5
(Chazaud and Rossant, 2006). E4.5 ApcMin/Min embryos harboring the
PEE-GFP transgene had more ﬂuorescent epiblast cells than wildtype
and heterozygote littermates of a similar size (n=6; Fig. 4E, F, G),
conﬁrming that canonical Wnt signaling regulates the expression of
the transgene. Interestingly, while β-catenin accumulates in the
epiblast and in the PrE of these embryos (Chazaud and Rossant,
2006); Fig. S4E, F), PEE-GFP expression remains restricted to the
epiblast.
Our results suggest that canonical Wnt signaling regulates Nodal
expression in the preimplantation epiblast through the PEE, and that
additional interactions are required to restrict PEE activity to the
epiblast.
The ASE-YFP marks subsets of cells in the PrE and in the early epiblast
The ASE-YFP transgene is expressed both in the epiblast and in the
PrE, and generally shows more diverse expression patterns than the
PEE-GFP transgene. To characterize this diversity and its dynamics, a
total of eighty-eight ﬂuorescent ASE-YFP embryos, sired by homozy-
gous males, were analyzed. The identity of YFP-positive cells was
established, based on embryo morphology and the cells' location.
Embryos recovered between E3.25 and E3.75 were all blastocysts
showing no evidence of PrE formation. 75% of these embryos had
YFP-positive cells in the ICM only (n=15/20; Fig. 5A). Embryos
recovered between E3.75 and E4.0 were late blastocysts with a visible
PrE layer (Plusa et al., 2008). Most had YFP-positive cells in both the
epiblast and the PrE (n=8/10). This was also the predominant pattern
(n=30/38) in embryos collected between E4.0 and E4.5. YFP-positive
cells in the TE, a rare occurrence, were detected either before PrE
formation, or later at the abembryonic pole of E4.5 implanting
embryos (n=5/20 and n=3/38 respectively). The distribution of
YFP-positive cells per lineage is shown in Fig. S5A.
To reconstruct in detail the dynamics of the ASE-YFP transgene's
expression, we decided to stage the embryos by counting the total cell
number (TCN) of each embryo (Fig. S5B). Although not without
caveat, because of apoptosis, the TCN is a more reliable criteria than
the time of dissection to evaluate the relative developmental stages of
different blastocysts (Copp, 1978; Plusa et al., 2008). Depending on
their TCN embryos were thus assigned to classes 20 cells apart.
In E3.5 blastocysts without morphological evidence of the PrE
layer (n=18), the number of YFP-positive cells in the ICM varied
between 1 and 4 (median=2; Fig. 5B, C). YFP-positive nuclei could be
detected in the PrE layer as soon as it started to form, but the
Fig. 4. E4.5 PEE-GFP expression is regulated byWnt/β-catenin signaling. (A) Conserved regions upstream of the Nodal gene. Horizontal lines represent genomic sequences upstream
of Nodal transcription start site. Interlinked black or green boxes represent non-repetitive regions with sequence identity above 68% (human) and 64% (cow) relative to mouse. The
125 bp long conserved sequence (green box) identiﬁed within the PEE region is noted PEE*. The open white box represents the 5′ end of the ﬁrst Nodal exon. Green and grey shaded
areas represent the PEE, NDE and AIE/LSE regulatory regions as originally described (Norris and Robertson, 1999; Saijoh et al., 2005; Vincent et al., 2004). TSS: Transcription start site.
PEE: proximal enhancer element. NDE: node element. AIE/LSE: asymmetric enhancer/ left side-speciﬁc enhancer. (B) Potential transcription factor binding sites in the 125 bp PEE*
sequence. The x-axis indicates site positions within the sequence. The y-axis reﬂects their statistical signiﬁcance/how long a random sequence should be to contain a site as well
matched to the PSSM. Matches relating to the Wnt pathway are in blue. The best 2 hits in the sequence were for LEF1-TCF1. Its PSSM is shown with the bases found in the
corresponding PEE* sequence displayed on a grey background. (C) E4.5 wildtype littermate of the β-catenin−/− embryo shown in (D). Both carry the PEE-GFP transgene. There is no
expression of the transgene in β-catenin−/− embryos. (E) E4.5wildtype littermate of the ApcMin/Min embryo shown in (F). Both carry the PEE-GFP transgene. More ﬂuorescent cells are
seen in the ApcMin/Min embryo. GFP (green; maximum intensity projections of confocal stacks) and cortical actin (red; single confocal sections) are detected as before. (G) Comparison
of the number of GFP-positive cells in 4 ApcMin/Min mutant embryos and in 4 littermates of similar size (1 wildtype, 3 ApcMin/+ ). PEE-GFP is expressed in a greater number of epiblast
cells in ApcMin/Min embryos (Mann–Whitney test, pb1%). Epi: epiblast; PrE: primitive endoderm. Scale bar=25 μm.
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embryos (Fig. 5D–I). In the epiblast, the YFP is at ﬁrst present in a
small number of nuclei (Fig. 5E–G), but in implanted E4.5 embryos it
tends to mark a majority of epiblast cells (Fig. 5H, I). An analysis of
Nodal expression was conducted by in situ hybridization to allow for
comparison. Nodal transcripts were detectable only from the late
morula stage (n=1/18, data not shown) and were consistently
observed in ICM cells of early to hatched blastocysts (Fig. 5J–L). At
E4.5 the majority of embryos harbored Nodal expression in both ICMderivatives, with the PrE expression appearing stronger in some cells
than in others (Fig. 5M, n=61/86). A fraction of E4.5 embryos
(Fig. 5N, n=25/86) and all E5.0 embryos (Fig. 5O, n=12/12) showed
expression exclusively in the epiblast, indicating that Nodal is
downregulated in the PrE and its derivatives shortly after implanta-
tion. Nodal transcripts were however detected again in the VE at E5.25
(Fig. 5P, n=9/13).
ASE-YFP expression is thus consistent with that of Nodal in the ICM,
the epiblast and the PrE, suggesting the likely involvement of the ASE
Fig. 5. Heterogeneous ASE-YFP expression in the ICM, the epiblast and the PrE between E3.5 and E4.5. (A) Distribution of ﬂuorescent ASE-YFP embryos per type of expression proﬁle
according to dissection time. (B-I) ASE-YFP-positive embryos for eight TCN classes. Lower left-hand corner numbers give the TCN range for each class. YFP (green; maximum intensity
projections of confocal stacks) and cortical actin (red; single confocal sections) are detected as before. (J–P) Nodal expression between E3.5 and E5.25 as detected by ISH. As TCN
could not be determined for these embryos, they were staged according to morphological criteria. (J) E3.5 mid blastocyst. (K) E3.5 expanding blastocyst. (L) E4.0 expanded
blastocyst. (M) and (N) E4.5 implanted blastocysts. (O) E5.0 embryo. (P) E5.25 embryo. TE: Trophectoderm; ICM: Inner cell mass; PrE: Primitive endoderm; Epi: Epiblast; VE:
Visceral endoderm. Scale bar=25 μm.
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like for the PEE-GFP transgene, the heterogeneous expression of the
ASE-YFP transgene suggests intrinsic differences between cells within
the epiblast or the PrE. To investigate what distinguishes expressing
and non-expressing cells we ﬁrst focused on characterizing the
regulation of the ASE-YFP transgene in the blastocyst.Fig. 6. E4.5 ASE-YFP expression is dependent on Activin/Nodal signaling but not on Nodal or
the ASE-YFP transgene in the epiblast and in the PrE. (C) E4.5 wildtype littermate of the Fox
ASE-YFP embryos cultured for 14 h in the presence of DMSO alone (E) or 40μM SB-431542
pb5%) in the percentage of YFP-positive embryos (G), and in the percentage of YFP-positive c
F—maximum intensity projections of confocal stacks; C, D—single confocal sections) and cort
of confocal stacks) are detected as before. YFP+: Embryos containing at least one ﬂuoresceNodal and FoxH1 are dispensable for the preimplantation expression of
the ASE-YFP transgene
Although the ASE-YFP transgene is not expressed in E5.5 Nodal−/−
embryos (Fig. 1H), it is expressed earlier in these mutants. A majority
of the E4.5 Nodal−/− embryos analyzed expressed the transgene inFoxH1. (A) E4.5 wildtype littermate of the Nodal−/− embryo shown in (B). Both express
H1−/− embryo shown in (D). Both express the ASE-YFP transgene in the epiblast. E3.75
(F). Treatment with the inhibitor results in signiﬁcant decreases (Mann–Whitney test,
ells within these embryos (H), without affecting embryo growth (I). YFP (green; A, B, E,
ical actin (red; A, B, C, D—single confocal sections; E, F—maximum intensity projections
nt cell. Scale bar=25 μm.
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expression in the PrE, an array of patterns not signiﬁcantly different
from that of wildtype embryos. Similarly, the ASE-YFP transgene was
expressed in E4.5 FoxH1−/− embryos (n=3/4; Fig. 6C, D), but not in
E5.5 FoxH1−/− embryos (Fig. 1I), indicating that the expression of the
transgene is not FoxH1-dependent at the earlier stage. These results
raised the possibility that the transgene might not depend on TGFβ-
related signaling before implantation. E3.5 transgenic embryos were
cultured overnight in the presence of 40 μM SB-431542, a pharma-
cological inhibitor of the type I receptors Alk4, 5 and 7 (Inman et al.,
2002). At this concentration, chosen after preliminary toxicity tests
(see Materials and methods), the development of the embryos was
not signiﬁcantly affected, as assessed by TCN counting and Gata4
immunostaining (Fig. 6I; Fig. S6). The treatment nevertheless resulted
in a drastic reduction of the proportion of YFP-positive embryos, from
79% to 29%, and the cells that expressed the transgene did so at a
lower level than their counterparts in untreated embryos (Fig. 6E–H).
We conclude that, at E4.5, most of the activity of the ASE-YFP
transgene is dependent on Activin/Nodal-like TGFβ signaling.PrE formation and implantation are followed by increased ASE-YFP
expression in the epiblast
To analyze the dynamics of the ASE-YFP transgene activity, the
distribution of the YFP-positive cell fractionwithin each TCN class was
systematically compared to that of adjacent classes using a Mann–
Whitney non-parametric test (Fig. 7A). This analysis suggests there
are three phases in the activity of the transgene for the range
of embryonic size considered. During phases I and II the fraction of
YFP-positive cells appears stable (see also Fig. S5B). Transitions
between phases are however marked by an increase in the fraction of
YFP-positive cells. Although the transition between phases I and II
seems to involve a smaller difference than between phases II and III it
is nevertheless statistically signiﬁcant (αb0.05). What marks the
phase II to phase III transition is a signiﬁcant increase in the variance
of the distributions (αb0.001).
The study of embryos within each class, as well as previous reports
(Fig. 5B–I; (Copp, 1978; Plusa et al., 2008), indicate the observed
transitions follow important developmental events, the onset of
epiblast and PrE precursors segregation for the ﬁrst, and the onset of
implantation for the second (Fig. 7A). How these events, which herald
drastic changes in the physiology of the embryo, may affect the
activity of the Nodal/Activin pathway is currently unclear.
To ﬁnd out the dynamics of epiblast and PrE subpopulation within
YFP-positive cells, twenty-six embryos were co-immunostained for
the PrE speciﬁc marker Gata4 and the YFP (Chazaud et al., 2006; Plusa
et al., 2008) (Fig. 7B–F). In phase I embryos where PrE and epiblast
precursors have not yet segregated, double stained nuclei show that
YFP-positive cells can belong to the population of committed PrE
precursors (Fig. 7B). The YFP-positive fraction then reaches a peak of
only 14% of PrE (Gata4-positive) cells in phase II and declines
afterwards, a dynamic consistent with the absence of ASE-YFP
expression in the VE, a PrE derivative, by E5.0 (Fig. 7E, F).Fig. 7. Increase of ASE-YFP expression in the nascent epiblast correlates with Nanog downregu
the evolution of this cell population. Transitions from phase I to phase II and from phase II to p
the percentage of YFP-positive cells between the 81–100 and the 101–120 TCN classes, (red
phase II and phase III embryos. X-axis: TCN range; y-axis: percentage of YFP-positive cells. (B-
projections of confocal stacks). Cortical actin (blue; single confocal sections) is detected as b
numbers for these embryos are plotted against their TCN in (E), and their distribution dynam
underlying heterogeneity. (G–I). IF detection of YFP (green) and Nanog (red) in ASE-YFP em
confocal sections). Double-positive (YFP/Nanog) cells appear in yellow. Nanog- and YFP-p
distribution dynamics is shown in (K). White arrowheads indicate double-positive YFP/Na
provides an estimate, based on the result in (F), of the fraction of YFP-positive cells that belo
epiblast and coincides with the disappearance of Nanog in this layer. TCN: Total cell numbeExpression of the ASE-YFP transgene in epiblast cells correlates with
Nanog downregulation
Double staining with Gata4 showed that the share of PrE cells
within the YFP-positive cell population decreases from 39.5% in phase
II to 18.6% in phase III (Fig. 7F). Concomitantly, ASE-YFP-positive cells
become more prominent in the epiblast (Fig. 5I, 6A, C; Fig. S5A). The
pluripotency factor Nanog also displays a heterogeneous expression
pattern in the epiblast of E4.5 embryos (Nichols et al., 2009; Plusa et
al., 2008). However, unlike that of ASE-YFP,Nanog expression has been
reported to decrease between E3.5 and E5.0 (Chambers et al., 2003;
Hart et al., 2004; Nichols et al., 2009). To determine whether there is a
correlation between these two dynamics, 25 transgenic embryoswere
co-immunostained for Nanog and YFP. The dynamics of the Nanog-
positive and YFP-positive cell populations appear to go in opposite
directions, with the size of the former declining as the embryos
develop (Fig. 7J, K). Strongly double-stained nuclei are detected in the
ICM of phase I embryos, suggesting the ASE-YFP transgene marks
epiblast precursors as well as PrE precursors (Fig. 7G). In contrast,
only a few weakly double-stained cells are detected in the epiblast of
embryos from phases II and III (Fig. 7H, I). Furthermore, the Nanog-
positive and the YFP-positive cell populations in the epiblast become
exclusive of each other, exhibiting complementary patterns in
individual phase III embryos (Fig. 7H, I, K). We noticed also the
presence of cells that express neither of the two markers in the
epiblast of peri-implantation embryos (Fig. 7I). However, such
double-negative cells are most apparent in embryos from phase III,
where their presence correlates with a decrease in the number
of Nanog positive cells and a greater variability in the number of
ASE-YFP-positive cells (Fig. 7A; Fig. S5B).
Together with the Gata4 data, these results suggest the heteroge-
neity in the activity of the ASE-YFP transgene does not strictly relate to
the establishment of epiblast or PrE identity, but may instead concern
the emergence of distinct cell identities within these cell layers.
Discussion
Conservation of canonical Wnt/β-catenin signaling in the mouse
blastocyst
The PEE-GFP transgene is expressed from the blastocyst stage
onward. Analysis of this expression in β-catenin−/− and ApcMin/Min
embryos demonstrates it is dependent on canonical Wnt/β-catenin
signaling, and provides for the ﬁrst time evidence of Wnt/β-catenin
activity in the nascent epiblast. Furthermore, the epiblast-speciﬁc
expression of the transgene in ApcMin/Min mutant embryos indicates
other interactions, either inductive in the epiblast and/or repressive in
the PrE, are required to generate this pattern.
Several ligands and receptors of the canonical Wnt/β-catenin
signaling pathway are present in the E3.5–E4.5 blastocyst (Hamatani
et al., 2004; Kemp et al., 2005;Wang, 2004), but its activity also depends
on the effectors and antagonists involved. TCF3, a LEF/TCF family
member known as a repressor of organizer genes in Xenopus, zebraﬁsh
andmouse (Houston et al., 2002; Kim et al., 2000;Merrill et al., 2004) islation. (A) Statistical analysis of YFP-positive cells distribution identiﬁes three phases in
hase III are respectivelymarked by, (black *) a signiﬁcant increase of themedian value of
*) a signiﬁcant increase in the variance of the percentage of YFP-positive cells between
D) IF detection of YFP (green) andGATA4 (red) in ASE-YFP embryos (maximum intensity
efore. Double-positive (YFP/GATA4) cells appear in yellow. Gata4- and YFP-positive cell
ics is shown in (F). ASE-YFP expression marks a small fraction of PrE cells, revealing an
bryos (maximum intensity projections of confocal stacks). Cortical actin (blue; single
ositive cell numbers for these embryos are plotted against their TCN in (J) and their
nog. The open arrowhead indicates a double-negative cell. The red-dotted line in (K)
ng to the PrE. The increase in the number of YFP-positive cells mostly takes place in the
r. Scale bar=25 μm.
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alsoacts predominantly as a transcriptional repressor inmESCs,where it
is considered a key pluripotency factor (Cole et al., 2008). Tcf3 knock-
down experiments in mESCs elicited upregulation of Nodal expression
(Cole et al., 2008). A hypothesis consistent with the expression proﬁle
of the PEE-GFP transgene is that Wnt/β-catenin signaling releases
TCF3-mediated repression of the transgene, which is then expressed
thanks to an epiblast-speciﬁc interaction. Possible activators of the
transgene include other members of the LEF/TCF family, Lef1, Tcf1 or
Tcf4, which interact with β-catenin to activate transcription (Arce et al.,
2006). However, there is currently no certainty on the presence of
either of these factors in E3.5 to E4.5 blastocysts.
Expression of BAT-Gal, a reporter transgene for canonical Wnt
signaling containing multimerized LEF/TCF binding sites, is not
detected before E5.5 (Kemler et al., 2004; Na et al., 2007). The earlier
expression of the PEE-GFP transgene may result from greater
sensitivity of the ﬂuorescent reporter compared to β-galactosidase.
It may also result from the interaction of the PEE with factors other
than LEF/TCF family members, possibly synergizing with LEF/TCF
family members. While our analysis of the conserved PEE sequence
focused on two LEF/TCF binding sites, putative binding sites for other
transcription factors were identiﬁed in their vicinity. Future analysis
will tell whether they contribute to PEE-GFP activation.
Early clustering of PEE-GFP expressing cells in the preimplantation
epiblast raises the possibility that they respond to a localized,
symmetry-breaking, signal. No asymmetrical expression has been
reported for the various Wnt ligands expressed in the embryo at this
stage. Nuclear β-catenin has however been detected transiently at
E4.5, in a single polar TE cell close to the PrE, in 15% of the embryos
analyzed (ChazaudandRossant, 2006). It has not yet been linked to the
establishment of later, post-implantation, AP polarity. This data and
our results nevertheless suggest the possibility of a Wnt/β-catenin-
dependent symmetry-breaking signal at E4.5. β-catenin loss-of-
function and constitutive activation of canonical Wnt signaling both
lead to defective proximo-distal patterning, suggesting localized
activation of this pathway is important to establish initial asymmetries
(Chazaud and Rossant, 2006; Huelsken et al., 2000; Morkel et al.,
2003). Nodal signaling is also critical for the proper establishment of
AP polarity (Brennan et al., 2001; Mesnard et al., 2006; Yamamoto
et al., 2004). Yet, Nodal expression appears unaffected from E4.5 in
β-catenin mutant embryos (Figs. S4G, H; Morkel et al., 2003).
Furthermore, PEE deletion at the Nodal locus does not affect this
process (Vincent et al., 2003), demonstrating the PEE is not the
conduit via which Wnt/β-catenin signaling governs the establish-
ment of the embryonic axes at early stages. On the other hand, the
expression of the Nodal co-receptor Cripto is directly under the
control of canonical Wnt signaling (Hamada et al., 2007; Morkel
et al., 2003). This situation may share some similarities with that in
Xenopus. Although some Xenopus Nodal-related genes harbor
numerous LEF/TCF binding sites in their cis-regulatory region, the
main fashion in which Wnt/β-catenin signaling polarises Activin/
Nodal activity is via indirect regulation of the production of activin
receptor Acvr2a (Hyde and Old, 2000; Martello et al., 2007). The
PEE-GFP transgene will be a valuable tool to dissect further the
contribution of Wnt/β-catenin signaling to Nodal regulation and
the establishment of AP polarity in the mouse embryo.
Conservation of early TGFβ signaling in the mouse blastocyst
The expression of the ASE-YFP transgene in the blastocyst is
unaffected in Nodal−/− or FoxH1−/− embryos, but drastically reduced
after treatment with SB-431542. This strengthens the case for the
implication of factors other than Nodal and FoxH1 in Activin/Nodal
signaling before implantation. In Xenopus, zebraﬁsh, chick and sea-
urchin, there is consistent evidence of another TGFβ family member
acting upstream of early Nodal expression (Birsoy et al., 2006;Dohrmann et al., 1996; Hagos et al., 2007; Range et al., 2007; Skromne
and Stern, 2001). Vg1 is in Xenopus the prototype of a maternally
deposited TGFβ-related ligand that is required to form the organizer
and the mesoderm (Birsoy et al., 2006). Vg1-related molecules of
maternal origin identiﬁed in Zebraﬁsh and in sea-urchin appear to
have similar properties (Dohrmann et al., 1996; Hagos et al., 2007;
Range et al., 2007). Signaling from these factors is transduced by
Smad2,3 and therefore contributes to the expression of Nodal-
related genes via the conserved auto-regulatory loop. There are two
Vg1-related factors in the mouse, Gdf1 and Gdf3 (Chen et al., 2006;
Cheng et al., 2003; Wall et al., 2000). However, neither of them
appears capable of activating the Smad2,3 pathway at physiological
concentrations (Andersson et al., 2007; Levine et al., 2009; Tanaka
et al., 2007). Their main effect on Nodal is to enhance its signaling
range via the formation of heterodimers (Tanaka et al., 2007). Gdf3 is
expressed in the ICM and in the epiblast of E3.5 to E4.5 mouse
blastocyst, and this expression persists in Nodal−/− embryos ((Levine
and Brivanlou, 2006), Figs. S7A, B). Gdf3 expression is also present in
E5.5 Nodal−/− embryos (Figs. S7C, D), where the ASE-YFP transgene is
not expressed, suggesting Gdf3 cannot replace Nodal in vivo. Similarly,
Gdf1 expression is not affected in post-implantation Nodal−/−
embryos (Figs. S7E-H). Better candidate ligands for the early
activation of the ASE-YFP transgene may thus be activins, which are
present in oviduct, uterine epithelia and blastocysts prior to
implantation (Albano et al., 1993; Albano and Smith, 1994). A recent
report suggests Activins are responsible for the activation of Smad2/3
signaling in the VE of E5.5 embryos (Yamamoto et al., 2009). The
presence of one of these ligands at peri-implantation stages could
explain the early ASE-YFP expression in Nodal−/− mutant embryos.
Origin and signiﬁcance of ASE-YFP heterogeneous expression
An interesting aspect of ASE-YFP expression is its heterogeneity at
early stages. The ASE-YFP transgene can mark both epiblast and PrE
precursors, at a time when they appear committed to their fates but
have not yet segregated, suggesting Activin/Nodal signaling is not
absolutely required to specify these lineages (Plusa et al., 2008).
Restriction of the transgene's expression to a small number of cells in
each precursor population suggests instead that Activin/Nodal
signaling acts early on to promote the emergence of differences
within each tissue layer.
Nodal is expressed in the PrE up to the time of implantation, after
which it is downregulated. Expression of the ASE-YFP transgene is
only ever detected in a subset of PrE cells, as is the case for Hex, Pem,
Lefty1 and Cer1 (Chazaud et al., 2006; Takaoka et al., 2006; Torres-
Padilla et al., 2007). The PrE gives rise to parietal endoderm and VE. A
study of blastocyst outgrowths suggested the involvement of
Smad2,3-dependent signaling in the regulation of parietal endoderm
formation (Roelen et al., 1998). A time-lapse study found that the
anterior VE at E5.75 contains descendants of E4.75 Cer1-expressing
PrE cells that havemaintained this expression throughout, arguing for
an early speciﬁcation of their fate (Torres-Padilla et al., 2007). Further
lineage and functional studies will thus be necessary to assess how
Activin/Nodal signaling affects the allocation of PrE cells to their
possible fates.
Contrary to what happens in the PrE, a majority of epiblast cells
end up expressing the ASE-YFP transgene, highlighting its usefulness
as a marker of the transition undergone by the tissue as a whole
during implantation (Chambers et al., 2003; Hart et al., 2004; Pelton
et al., 2002). One hypothesis is that expression of the ASE-YFP
transgene marks nascent epiblast cells that have initiated their
transition to a distinct status. The Smads activate transcription via
chromatin remodeling (Dahle et al., 2010; Ross et al., 2006), a mode
of action possibly unique among transcription factors. This identiﬁes
Smads as good candidates for regulating the process that locks in
developmental decisions, preventing reversion to a previous status.
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epiblast to a broadly ASE-YFP-positive one reﬂects either an
increased exposure of epiblast cells to Activin/Nodal signaling and/
or the fact that their capacity to respond to it is itself regulated.
Correlation between the gradual elimination of Nanog from the
epiblast and increased ASE-YFP expression in this tissue suggests a
Nanog-dependent antagonism of Activin/Nodal signaling in Nanog-
expressing cells, effective regardless of the ligand involved. This does
not necessarily imply a direct interaction between Nanog and
components of the signaling pathway. Indeed, the fact that the
correlation between Nanog downregulation and ASE-YFP expression
is not manifest before a certain stage suggests that other factors are
also implicated. However, Nanog harbors some similarity with
Smad4 (Hart et al., 2004), and has been shown to form a complex
with pSmad2/3 in hESCs and mEpiSCs, with the effect of dampening
the transcriptional activity of the pathway (Vallier et al., 2009a).
Although such an interaction has not been characterized in mESCs
yet, Nanog knock-down in mESCs does result in an upregulation of
Nodal expression (Sharov et al., 2008; Vallier et al., 2009b) indicating
the implication of Nanog in a repression of Activin/Nodal signaling is
a recurrent feature of early mammalian development.
Another interesting aspect of the dynamic of ASE-YFP expression is
the variability in the number of ASE-YFP-positive cells seen at E4.5 in
individual embryos of a comparable size. The mixed genetic
background of our embryos may contribute to this variability. It
could result also from the ability of individual embryos to respond and
to adapt to their changing environment at this stage. So the variability
in ASE-YFP expression at E4.5 may reﬂect how in each embryo the
activity of the Activin/Nodal pathway is adjusted in response to its
particular circumstances.
The study of the PEE-GFP and ASE-YFP transgenes provides new
insights into the activities of the canonical Wnt signaling and Activin/
Nodal signaling pathways at pre- and peri-implantation stages, and
shows how these activities contribute to the regulation of early Nodal
expression. Interestingly, our transgenes only partially recapitulate
this early expression, further highlighting the complexity of Nodal
regulation before implantation. Additional studies will establish the
contributions of other regulatory sequences and synergistic interac-
tions at the endogenous locus in the generation of Nodal full
expression proﬁle.
The transgenes' expression patterns reveal unsuspected hetero-
geneity in the epiblast and the primitive endoderm. Lineage studies
combined with the use of the transgenes will show how this
heterogeneity relates to the emergence of later cell identities.
Our results indicate that the activity of the Activin/Nodal signaling
pathway may be restrained by the molecular machinery of pluripo-
tency. This interaction could delay the action of the Activin/Nodal
pathway in cell-fate speciﬁcation in the epiblast until implantation.
The ASE-YFP and PEE-GFP transgenes will be useful tools to investigate
the mechanisms promoting epiblast maturation in vivo, and to
compare them with processes underlying the early steps of differen-
tiation in mESCs.
Supplementarymaterials related to this article can be found online
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